Patient P-02212
Synthetic patientMETA-24 · Day 179 · 55–64 · M · baseline S17Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
6%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S17
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Toxicity-6
- GI instability-4
- Inflammatory activity-4
- Treatment adherence+2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable60 min
stable · -1.7 vs previous 14 d
Sleep duration
Wearable6.8 h
stable · +0.2 vs previous 14 d
Energy level
Daily log7.2/10
improving · +0.4 vs previous 14 d
Steps
Wearable6,544
stable · +99 vs previous 14 d
GI burden
Companion11.2/100
improving · -2.4 vs previous 14 d
Adherence
Companion95 %
stable · +2.0 vs previous 14 d
Sleep quality
Wearable58.4/100
improving · +3.8 vs previous 14 d
Glucose, CGM daily mean
CGM134 mg/dL
stable · -0.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 99 from the failing basin, 13 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +6.1
- Proteinsupporter · GI -3.5 next day
Main detractors to watch
- Antibiotic courseperturbation · steering -4.7
- Low-HRV stretchperturbation · steering -2.7
- Dietary driftperturbation · steering -2.6
- Alcohol on dosing daysperturbation · steering -1.8
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.5supporter · 95%
- Histamine load-1no signal · 31%
- Dietary fat load+0.7no signal · 21%
- Ultra-processed food-0.7no signal · 21%
- Caffeine+0.6no signal · 15%
- Insoluble fibre+0.3no signal · 15%
- Simple carbohydrates-0.2no signal · 15%
- Alcohol-0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
Microbiome
Shannon diversity 4.5 · butyrate capacity 66/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 69 ms
- Sleep
- 6.8 h
- Steps
- 6,335
- Resting HR
- 55 bpm
Daily log: GI score 11, nutritional resilience 68, adherence 95.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.